Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mauro

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 15, 2010
Identification of carotid 'vulnerable plaque' by contrast-enhanced ultrasonography: correlation with plaque histology, symptoms and cerebral computed tomographyG L Faggioli, R Pini, R Mauro, et al.
Histology and Histopathology|June 2, 2011
C-reactive protein and embolization during carotid artery stenting. A serological and morphological studyG Faggioli, S Fittipaldi, R Pini, et al.
The American Journal of Pathology|November 20, 2012
A simplified murine intimal hyperplasia model founded on a focal carotid stenosisMing Tao, Christine R Mauro, Peng Yu, et al.
Critical Reviews in Oncology/Hematology|June 16, 2024
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitorsFrancesca R Mauro, Anna Maria Frustaci, Andrea Visentin, et al.
Blood Reviews|February 8, 2024
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelinesMalgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, et al.
Expert Review of Hematology|July 4, 2018
Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemiaFrancesca R Mauro, Maria D Caputo, Serena Rosati, et al.
Haematologica|October 26, 2010
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working groupStefano Molica, Francesca R Mauro, Diana Giannarelli, et al.
Haematologica|August 4, 2006
Clinical features and outcome of familial chronic lymphocytic leukemiaFrancesca R Mauro, Elena Giammartini, Massimo Gentile, et al.
Journal of Vascular Surgery|September 30, 2014
Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodelingChristine R Mauro, Kui Ding, Hui Xue, et al.
Haematologica|November 12, 2009
The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experienceStefano Molica, Francesca R Mauro, Vincenzo Callea, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 15, 2010
Identification of carotid 'vulnerable plaque' by contrast-enhanced ultrasonography: correlation with plaque histology, symptoms and cerebral computed tomographyG L Faggioli, R Pini, R Mauro, et al.
Histology and Histopathology|June 2, 2011
C-reactive protein and embolization during carotid artery stenting. A serological and morphological studyG Faggioli, S Fittipaldi, R Pini, et al.
The American Journal of Pathology|November 20, 2012
A simplified murine intimal hyperplasia model founded on a focal carotid stenosisMing Tao, Christine R Mauro, Peng Yu, et al.
Critical Reviews in Oncology/Hematology|June 16, 2024
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitorsFrancesca R Mauro, Anna Maria Frustaci, Andrea Visentin, et al.
Blood Reviews|February 8, 2024
Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelinesMalgorzata Mikulska, Chiara Oltolini, Emanuela Zappulo, et al.
Expert Review of Hematology|July 4, 2018
Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemiaFrancesca R Mauro, Maria D Caputo, Serena Rosati, et al.
Haematologica|October 26, 2010
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working groupStefano Molica, Francesca R Mauro, Diana Giannarelli, et al.
Haematologica|August 4, 2006
Clinical features and outcome of familial chronic lymphocytic leukemiaFrancesca R Mauro, Elena Giammartini, Massimo Gentile, et al.
Journal of Vascular Surgery|September 30, 2014
Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodelingChristine R Mauro, Kui Ding, Hui Xue, et al.
Haematologica|November 12, 2009
The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experienceStefano Molica, Francesca R Mauro, Vincenzo Callea, et al.
Pageof 14